Related Experiment Video

Updated: Jul 2, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Ischemic Preconditioning And Myocardial Infarction: An Update and Perspective

Eric R Gross1, Garrett J Gross

  • 1Medical College of Wisconsin, Department of Pharmacology and Toxicology, Milwaukee, WI 53226.

Drug Discovery Today. Disease Mechanisms
|August 15, 2008
PubMed

Insights

Ischemic preconditioning (IPC) offers promising therapeutic strategies against myocardial infarction, the leading cause of death. This review updates on IPC mechanisms, effects in aging/disease models, and potential treatments.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Myocardial infarction is a primary cause of mortality globally.
  • Coronary artery disease incurs substantial healthcare costs.
  • Ischemic preconditioning (IPC) research is advancing therapeutics for myocardial injury.

Purpose of the Study:

  • To provide an updated review of ischemic preconditioning (IPC).
  • To discuss the mechanisms and therapeutic potential of IPC in cardiac conditions.
  • To summarize current and future research directions in cardiac IPC.

Main Methods:

  • Literature review of preclinical and clinical studies on IPC.
  • Analysis of molecular and general mechanisms underlying IPC.
  • Evaluation of IPC's effects in aging and disease models.

Main Results:

  • IPC involves complex molecular pathways conferring cardioprotection.
  • IPC demonstrates efficacy in mitigating myocardial injury in various models.
  • Several therapeutics based on IPC show promise in trials.

Conclusions:

  • IPC represents a significant area for developing novel treatments for myocardial infarction.
  • Further research into IPC mechanisms and clinical translation is warranted.
  • Targeting IPC pathways could revolutionize cardiac care.

More Related Videos

A Modified Simple Method for Induction of Myocardial Infarction in Mice04:29

A Modified Simple Method for Induction of Myocardial Infarction in Mice

Published on: December 3, 2021

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...